---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-021123"
form_type: "8-K"
ticker: "EZRA"
cik: "0001812727"
company_name: "Reliance Global Group, Inc."
filed_at: "2026-05-04T23:59:59+00:00"
generated_at: "2026-05-14T23:59:56.353691+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Reliance Global Group invests $2M in Innervate Radiopharmaceuticals via LifeSci Global biotech arm

## Summary
- LifeSci Global (51% owned by Reliance) agrees to acquire 421,053 Innervate units at $4.75/unit for $2M total; $500K funded at closing.
- Innervate develops 18F-mFBG PET imaging for neuroblastoma; initial market ~$250M with potential $1B+ expansion in cardiovascular/neurodegenerative.
- Reliance subsidiary EIG issued a $2M promissory note at 7% interest to LifeSci Global to fund the investment; matures April 2031.
- CEO Beyman and director Korman have indirect equity in LifeSci Global and recused from board approval; Korman removed from all board committees.
- Company highlights potential Rare Pediatric Disease Priority Review Voucher if Innervate's product is approved, which could be monetized.

## SEC filing metadata
- accession: 0001493152-26-021123
- form_type: 8-K
- ticker: EZRA
- cik: 0001812727
- company_name: Reliance Global Group, Inc.
- filed_at: 2026-05-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812727/000149315226021123/0001493152-26-021123-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812727/000149315226021123/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-021123
- JSON: https://secwatch.observer/filing/0001493152-26-021123.json
- Plain text: https://secwatch.observer/filing/0001493152-26-021123.txt

## Key facts
- Debt Financings
  Reliance Global Group, Inc. incurred loan of up to $2,000,000 with LGG at 7% per annum maturing the fifth anniversary of the effective date of the Promissory Note (April 29, 2031).
  - Instrument: loan
  - Principal: up to $2,000,000
  - Counterparty: LGG
  - Rate: 7% per annum
  - Maturity: the fifth anniversary of the effective date of the Promissory Note (April 29, 2031)
  - Event: incurrence
  source text: company (“EIG”) that is a wholly-owned subsidiary of the Company, and LGG entered into a Promissory Note (the “Promissory Note”) in the maximum aggregate principal amount of $2,000,000. The Promissory Note bears interest at 7% per annum, compounded annually and accruing daily. Advances under the Promissory Note may be made by EIG to LGG from time to time at
  evidence_url: https://www.sec.gov/Archives/edgar/data/1812727/000149315226021123/0001493152-26-021123-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.